Aptinyx to Participate in Upcoming Virtual Investor Conferences
November 10 2020 - 8:37AM
Business Wire
EVANSTON, Ill., November 10, 2020 – Aptinyx Inc. (Nasdaq: APTX),
a clinical-stage biopharmaceutical company developing
transformative therapies for the treatment of brain and nervous
system disorders, today announced that company management is
scheduled to participate in two upcoming investor conferences:
- A presentation during the Stifel 2020 Virtual Healthcare
Conference at 1:20 p.m. ET on Tuesday, November 17, 2020; and
- A pre-recorded fireside chat during the Piper Sandler 32nd
Annual Healthcare Conference. The virtual conference will be held
from December 1-3, 2020. The fireside chat will be available on the
company’s IR website.
These presentations will be available to view on the “Events and
Presentations” page in the “Investors & Media” section of
Aptinyx’s website at https://ir.aptinyx.com and will be archived on
Aptinyx’s website for 30 days following the event.
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company
focused on the discovery, development, and commercialization of
proprietary synthetic small molecules for the treatment of brain
and nervous system disorders. Aptinyx has a platform for discovery
of novel compounds that work through a unique mechanism to
modulate—rather than block or over-activate—NMDA receptors and
enhance synaptic plasticity, the foundation of neural cell
communication. The company has three product candidates in clinical
development in central nervous system indications, including
chronic pain, post-traumatic stress disorder, and cognitive
impairment associated with Parkinson’s disease. Aptinyx is also
advancing additional compounds from its proprietary discovery
platform, which continues to generate a rich and diverse pipeline
of small-molecule NMDA receptor modulators with the potential to
treat an array of neurologic disorders. For more information, visit
www.aptinyx.com.
Source: Aptinyx Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201110005300/en/
Investor and Media Contact: Nick Smith Aptinyx Inc.
ir@aptinyx.com or corporate@aptinyx.com 847-871-0377
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Apr 2023 to Apr 2024